Verapamil Inhibits Mitochondria-Induced Reactive Oxygen Species and Dependent Apoptosis Pathways in Cerebral Transient Global Ischemia/Reperfusion
Overview
Endocrinology
Authors
Affiliations
The prefrontal cortex is the largest lobe of the brain and is consequently involved in stroke. There is no comprehensive practical pharmacological strategy for ameliorating prefrontal cortex injury induced by cerebral ischemia. Therefore, we studied the neuroprotective properties of verapamil (Ver) on mitochondrial dysfunction and morphological features of apoptosis in transient global ischemia/reperfusion (I/R). Ninety-six Wistar rats were allocated into four groups: control, I/R, I/R+Ver (10 mg/kg twice 1 hour prior to ischemia and 1 hour after reperfusion phase), and I/R+NaCl (vehicle). Animals were sacrificed, and mitochondrial dysfunction parameters (i.e., mitochondrial swelling, mitochondrial membrane potential, ATP concentration, ROS production, and cytochrome c release), antioxidant defense (i.e., superoxide dismutase, malondialdehyde, glutathione peroxidase, catalase, and caspase-3 activation), and morphological features of apoptosis were determined. The results showed that mitochondrial damage, impairment of antioxidant defense system, and apoptosis were significantly more prevalent in the I/R group in comparison with the other groups. Ver decreased mitochondrial damage by reducing oxidative stress, augmented the activity of antioxidant enzymes in the brain, and decreased apoptosis in the I/R neurons. The current study confirmed the role of oxidative stress and mitochondrial dysfunction in I/R progression and indicated the possible antioxidative mechanism of the neuroprotective activities of Ver.
Zangouri V, Zaferani Arani H, Salimi Tabatabaee S Cureus. 2025; 17(1):e77985.
PMID: 40007918 PMC: 11850220. DOI: 10.7759/cureus.77985.
A Short Review on Advances in Early Diagnosis and Treatment of Ischemic Stroke.
Sun B, Wang Z Galen Med J. 2024; 12:e2993.
PMID: 39430040 PMC: 11491119. DOI: 10.31661/gmj.v12i0.2993.
Yang H, Xia Y, Ma Y, Gao M, Hou S, Xu S Neural Regen Res. 2024; 20(7):1900-1918.
PMID: 38993125 PMC: 11691458. DOI: 10.4103/NRR.NRR-D-24-00015.
Nesterowicz M, Lauko K, Dankowska K, Trocka D, Zendzian-Piotrowska M, Ladny J Front Pharmacol. 2023; 14:1293295.
PMID: 38089049 PMC: 10714945. DOI: 10.3389/fphar.2023.1293295.
Wang H, Li Z, Cao G, Tang L, Zhou R, Li C Mol Neurobiol. 2023; 60(10):5533-5547.
PMID: 37328677 DOI: 10.1007/s12035-023-03403-x.